Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Natriuretic peptides and the genomics of left-ventricular hypertrophy.

Heart failure clinics - 1 Jan 2010

Dries Daniel L

Abstract excerpt

Left-ventricular hypertrophy (LVH) is one of the strongest independent predictors of cardiovascular morbidity and mortality in the general population. Although hypertension and obesity are well-established, independent risk factors for the development of LVH, they explain less than 25% to 50% of the variance of left ventricular mass (LVM) in humans. A substantial body of evidence suggests that there is a genetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to Antihypertensive Agents
Share to Black or African American

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypertension

Share to Hypertrophy, Left Ventricular

Share to Risk Assessment

Share to Serine Endopeptidases

Share to United States

Source

Open in PubMed Open full text

Identifiers

PMID: 19945061
DOI: 10.1016/j.hfc.2009.08.007
PMCID: PMC2786820

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Natriuretic peptides and the genomics of left-ventricular hypertrophy.PMID 19945061Read ↗

Genes for left ventricular hypertrophy.Semantic proximity Read ↗

Genetic polymorphisms of the natriuretic peptide system in the pathogenesis of cardiovascular disease: what lies on the horizon?Semantic proximity Read ↗

Human genetics, natriuretic peptides and hypertensionSemantic proximity Read ↗

Genomic Profiling of Left and Right Ventricular Hypertrophy in Congenital Heart DiseaseSemantic proximity Read ↗

Identification and validation of Loci and candidate genes linked to cardiac hypertrophy.Semantic proximity Read ↗

Genetic markers of ventricular hypertrophy.Semantic proximity Read ↗

Clinical and genetic associations of asymmetric apical and septal left ventricular hypertrophySemantic proximity Read ↗

Heritability of left ventricular mass: the Framingham Heart Study.Semantic proximity Read ↗

Key genetic variants in the renin-angiotensin system and left ventricular mass in a cohort of Polish patients with heart failure.Semantic proximity Read ↗

Pharmacogenomics of the Natriuretic Peptide System in Heart Failure.Semantic proximity Read ↗

The role of genetic variants in angiotensin I converting enzyme, angiotensinogen and the angiotensin II type-1 receptor in the pathophysiology of heart muscle disease.Semantic proximity Read ↗

Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.